NCT03262181

Brief Summary

The purpose of this study is to determine differences in lower extremity landing biomechanics and real-world physical activity between individuals with patellar tendinopathy compared to individuals without patellar tendinopathy,and to determine the acute effects of an isometric loading intervention on lower extremity landing biomechanics in individuals with patellar tendinopathy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
43

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2017

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 22, 2017

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 25, 2017

Completed
21 days until next milestone

Study Start

First participant enrolled

September 15, 2017

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 20, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 20, 2018

Completed
Last Updated

February 19, 2019

Status Verified

February 1, 2019

Enrollment Period

7 months

First QC Date

August 22, 2017

Last Update Submit

February 15, 2019

Conditions

Keywords

ExercisePhysical ActivityBiomechanics

Outcome Measures

Primary Outcomes (5)

  • Difference in the change in mean internal knee extension moment during landing between groups

    Angular force or moment will be measured in Nm/kg\*m where "Nm" represents angular force and "kg\*m" represents normalization to body weight and height.

    Pre- and post-intervention condition (~30 minutes)

  • Difference in the change in mean internal hip flexion moment during landing between groups

    Angular force or moment will be measured in Nm/kg\*m where "Nm" represents angular force and "kg\*m" represents normalization to body weight and height.

    Pre- and post-intervention condition (~30 minutes)

  • Difference in the change in mean peak vertical ground reaction force during landing between groups

    Vertical ground reaction force will be measured in N(BW) where "N" is a measure of force and "BW" represents normalization to body weight.

    Pre- and post-intervention condition (~30 minutes)

  • Difference in the change in mean peak vertical ground reaction force loading rate during landing between groups

    Vertical ground reaction force loading rate will be measured in N(BW)/s where "N" is a measure of force and "BW" represents normalization to body weight and "s" is the time unit seconds.

    Pre- and post-intervention condition (~30 minutes)

  • Difference in the change in mean peak patellar tendon force during landing between groups

    Patellar tendon force will be measured in N(BW) where "N" is a measure of force and "BW" represents normalization to body weight.

    Pre- and post-intervention condition (~30 minutes)

Secondary Outcomes (3)

  • Difference in average steps-per-day between groups

    Day 1 - Day 7

  • Difference in average minutes of moderate-to-vigorous physical activity (MVPA) between groups

    Day 1 - Day 7

  • Difference in change in anterior knee pain (self-reported via visual analog scale (0-10)) between groups

    Pre- and post-intervention condition (~10 minutes)

Study Arms (2)

Isometric Exercise Condition

EXPERIMENTAL

The participant will perform 5 sets of a 45-second isometric contractions at 70% of their maximum voluntary isometric contraction (MVIC). During the 45-second contraction, the participant will be provided with visual biofeedback on a computer screen (70% MVIC target line and +/- 5% error lines). The participant will be instructed to produce a level of isometric quadriceps contraction that maintains the isometric torque output line as close the target line as possible and always between the two error lines.

Other: Isometric Exercise

Sham TENS Condition

SHAM COMPARATOR

Two electrodes of the Select System TENS unit (Empi, Inc., St. Paul, MN) will be placed on either side of the patellar tendon on the test limb. The same instruction script will be used for each participant, stating, "A surface electrode has been placed on either side of your patellar tendon. I will turn on the stimulation unit to emit a stimulus to your patellar tendon. This is a special sub-sensory stimulation treatment, so you will not feel anything during this period as the stimulus is set at a very low, non-detectable threshold. Please remain still during this 45-second period, letting your leg rest passively in the machine without contracting your leg muscles. After the 45-second period, the stimulation unit will be turned off and you will have a 2-minute rest period. We will repeat this same treatment/rest sequence 5 total times."

Other: Sham Transcutaneous Electrical Nerve Stimulation

Interventions

5 sets of 45-seconds quadriceps contraction, each followed by 2-minutes of rest.

Also known as: Therapeutic Exercise
Isometric Exercise Condition

5 sets of 45-seconds intervals without quadriceps contraction, each followed by 2-minutes of rest.

Also known as: Sham TENS
Sham TENS Condition

Eligibility Criteria

Age15 Years - 28 Years
Sexmale
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • The investigators will recruit a convenience sample of participants who meet the following overall criteria:
  • Age 15 and post-pubertal (confirmed by Pubertal Development Scale Questionnaire) - 28 years
  • Actively participating within an organized sport setting (high school, collegiate, club, competitive intramural sports) in their respective team's weekly training and competitions, quantified by a Tegner Activity Level Scale of at least 5.

You may not qualify if:

  • Any anterior knee pain with no patellar tendon abnormality on ultrasound assessment.
  • History of any knee joint surgery ever.
  • History of other (non-knee) lower extremity surgery in the last 1 year.
  • History of lower extremity injury in last 6 months (other than patellar tendinopathy).
  • An injection (corticosteroids, plasma-rich-protein, etc.) to the patellar tendon in the last 3 months.
  • Known history of osteoarthritis or current symptoms related to osteoarthritis (i.e. stiffness, swelling).
  • Participation in formal rehabilitation for patellar tendinopathy in prior 3 months
  • Known neurological disorders, including: stroke, multiple sclerosis, ALS, diabetic neuropathy, epilepsy, traumatic brain injury resulting in loss of consciousness, concussion within the last 6 months, cranial neural surgery, balance disorders.
  • Use of pacemaker or another implantable electronic device.
  • History of cardiac arrhythmia or any cardiac condition.
  • History of psychiatric disorder. \*
  • History of cancer in the brain or thigh musculature.
  • Pubertal Development Scale Score \< 12 (Stages 1-4)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sports Medicine Research Laboratory

Chapel Hill, North Carolina, 27599, United States

Location

MeSH Terms

Conditions

TendinopathyMotor Activity

Interventions

ExerciseExercise Therapy

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesTendon InjuriesWounds and InjuriesBehavior

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy Modalities

Study Officials

  • Darin A Padua, PhD, ATC

    Professor and Department Chair

    STUDY CHAIR
  • Laura E Stanley, DPT

    Graduate Research Assistant

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
Participants are masked to their group assignment until the end of the study. Investigator is masked to intervention condition.
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 22, 2017

First Posted

August 25, 2017

Study Start

September 15, 2017

Primary Completion

April 20, 2018

Study Completion

April 20, 2018

Last Updated

February 19, 2019

Record last verified: 2019-02

Locations